Cargando…
Structural insights into the binding of MMP9 inhibitors
Matrix Metalloproteinase are family of enzymes responsible for degradation of extracellular matrix. MMP9 (gelatinase B) is one of the common matrix metalloproteinase that is associated with tissue destruction in a number of disease states such as rheumatoid arthiritis, fibrotic lung disease, dilated...
Autores principales: | Tandon, Arpit, Sinha, Siddharth |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Biomedical Informatics
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046033/ https://www.ncbi.nlm.nih.gov/pubmed/21383916 |
Ejemplares similares
-
Matrix Metalloproteinase-9 (MMP9)—A Mediating Enzyme in Cardiovascular Disease, Cancer, and Neuropsychiatric Disorders
por: Rybakowski, Janusz K.
Publicado: (2009) -
Curcumin binds in silico to anti-cancer drug target enzyme MMP-3 (human stromelysin-1) with affinity comparable to two known inhibitors of the enzyme
por: Jerah, Ahmed, et al.
Publicado: (2015) -
Structural insight into the binding of C60-derivatives with enoyl-pyruvate transferase from Helicobacter pylori
por: Teimouri, Mohammad, et al.
Publicado: (2017) -
Structure based virtual screening of inhibitors for binding at the allosteric site of HCV RNA dependent RNA polymerase
por: Revikumar, Amjesh, et al.
Publicado: (2012) -
Insight into the mechanism of lipids binding and uptake by CD36 receptor
por: Tarhda, Zineb, et al.
Publicado: (2015)